Clinical diagnostics encompasses the detection, diagnosis, and monitoring of diseases and health conditions in patients. Utilizing advanced lab techniques and medical technologies, clinical scientists and healthcare professionals analyze samples such as blood, urine, and tissue to identify biomarkers, pathogens, and other indicators of illness. From point of care testing (POCT) to precision medicine approaches, clinical diagnostics plays a crucial role in early intervention, treatment planning, and disease management. Explore how this field empowers clinicians to deliver accurate diagnoses and improve patient outcomes.
The cobas p post-analytical unit is an automated storage device for sample archiving after the analytical phase. Major benefits of the solution are: • Shorter Turnaround Time (TAT). • Reduction/elimination of manual handling for archiving, retrieval, and wasting. • Reduction/elimination of biohazard exposure. • Continuous quality monitoring of the storage area and complete traceability of all processes (storage, retrieval, and…
Task targeted automation systems that mechanize one or several pre-analytical steps like e. g. - pre-sorting, - centrifugation, - decapping, - aliquoting, - bar coding and sorting / archiving. The systems increase the quality and efficiency in pre-analytics and reduce the operator's exposure to potentially hazardous biological material.
The centerpiece of the Labotix product line is the Rapid Response Universal Specimen Handling (RRUSH®) system. RRUSH is an open automation solution that contains all of the components necessary to automate today’s clinical lab. The system’s purpose is to transport and sort specimen containers and deliver them to appropriate analysis or storage areas, ready for processing. The Labotix system is a configuration of automated modu…
The MiniBlock® is an easy-to-use reaction block designed for parallel synthesis and screening. Its unique valve body design enables processes where filtration is critical, including solid-phase organic synthesis, use of scavenger resins with solution phase synthesis and parallel purification via Solid-Phase Extraction (SPE).Make the choice many chemists have made to increase productivity, more so than any other similar tool.…
The Meritas® cTnI test is a single use, rapid one-step fluorescence immunoassay for in vitro quantitative determination of cTnI in EDTA anticoagulated human whole blood and plasma specimens. Meritas® cTnI test can both be used as an aid in the diagnosis of MI but also for risk stratification of patients with MI in respect to their relative risk of mortality. The test is to be used with the Trinity Biotech Meritas® POC Analyzer…
The Meritas® cTnI test is a single use, rapid one-step fluorescence immunoassay for in vitro quantitative determination of cTnI in EDTA anticoagulated human whole blood and plasma specimens. Meritas® cTnI test can both be used as an aid in the diagnosis of MI but also for risk stratification of patients with MI in respect to their relative risk of mortality. The test is to be used with the Trinity Biotech Meritas® POC Analyzer…
The VES-MATIC 30 is an automated bench-top analyser for the direct measurement of erythrocyte sedimentation rate in EDTA sample tubes. This compact analyser can analyse up to 30 samples at a time and provides automated mixing and reading. •Correlated to ICSH Westergren reference method •Barcode reader for positive sample identification •Results within 35 minutes •Bi-level QC material provides assurance of accuracy, precision a…
The Vet abc is simple to operate and produces a complete three part differential blood count in only 90 seconds. When the measurement is started, 12 µl of EDTA whole blood is automatically aspirated - no sample preparation is necessary. The results are automatically transferred to your practice software program. The operator-friendly reagent pack concept renders daily maintenance procedures unnecessary. The proven impedance te…
MammaPrint Provides Individualized Metastasis Risk Assessment for Your Breast Cancer Patients MammaPrint is the first FDA-cleared IVDMIA breast cancer recurrence assay. The unique 70-gene signature of MammaPrint provides you with the unprecedented ability to identify which early-stage breast cancer patients are at risk of distant recurrence following surgery, independent of Estrogen Receptor status and any prior treatment. Unl…
The BluePrint Molecular Subtyping Profile combined with the patient's MammaPrint test result, provides a greater level of clinical information to assist in therapeutic decision-making. BluePrint is an 80-gene expression signature which classifies breast cancer into Basal-type, Luminal-type and ERBB2-type cancers. An increasing body of evidence in the medical community suggests that breast cancer patients within these molecular…
